Cargando…
CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351628/ https://www.ncbi.nlm.nih.gov/pubmed/30696805 http://dx.doi.org/10.1038/s41408-019-0171-2 |
_version_ | 1783390616087953408 |
---|---|
author | Kuravi, Sudhakiranmayi Parrott, Elizabeth Mudduluru, Giridhar Cheng, Janice Ganguly, Siddhartha Saunthararajah, Yogen Jensen, Roy A. Blagg, Brian S. McGuirk, Joseph P. Balusu, Ramesh |
author_facet | Kuravi, Sudhakiranmayi Parrott, Elizabeth Mudduluru, Giridhar Cheng, Janice Ganguly, Siddhartha Saunthararajah, Yogen Jensen, Roy A. Blagg, Brian S. McGuirk, Joseph P. Balusu, Ramesh |
author_sort | Kuravi, Sudhakiranmayi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6351628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63516282019-01-30 CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas Kuravi, Sudhakiranmayi Parrott, Elizabeth Mudduluru, Giridhar Cheng, Janice Ganguly, Siddhartha Saunthararajah, Yogen Jensen, Roy A. Blagg, Brian S. McGuirk, Joseph P. Balusu, Ramesh Blood Cancer J Correspondence Nature Publishing Group UK 2019-01-29 /pmc/articles/PMC6351628/ /pubmed/30696805 http://dx.doi.org/10.1038/s41408-019-0171-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Kuravi, Sudhakiranmayi Parrott, Elizabeth Mudduluru, Giridhar Cheng, Janice Ganguly, Siddhartha Saunthararajah, Yogen Jensen, Roy A. Blagg, Brian S. McGuirk, Joseph P. Balusu, Ramesh CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas |
title | CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas |
title_full | CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas |
title_fullStr | CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas |
title_full_unstemmed | CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas |
title_short | CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas |
title_sort | cdc37 as a novel target for the treatment of npm1-alk expressing anaplastic large cell lymphomas |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351628/ https://www.ncbi.nlm.nih.gov/pubmed/30696805 http://dx.doi.org/10.1038/s41408-019-0171-2 |
work_keys_str_mv | AT kuravisudhakiranmayi cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT parrottelizabeth cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT muddulurugiridhar cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT chengjanice cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT gangulysiddhartha cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT saunthararajahyogen cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT jensenroya cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT blaggbrians cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT mcguirkjosephp cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas AT balusuramesh cdc37asanoveltargetforthetreatmentofnpm1alkexpressinganaplasticlargecelllymphomas |